Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings Co's cash flow for dividends for the
three
months ended in Dec. 2025 was 円0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was 円-57 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Noevir Holdings Co's quarterly payment of dividends
declined
from Jun. 2025 (円-4 Mil) to Sep. 2025 (円0 Mil) but then
stayed the same
from Sep. 2025 (円0 Mil) to Dec. 2025 (円0 Mil).
Noevir Holdings Co's annual payment of dividends
increased
from Sep. 2023 (円-7,341 Mil) to Sep. 2024 (円-7,522 Mil) and
increased
from Sep. 2024 (円-7,522 Mil) to Sep. 2025 (円-7,683 Mil).
Noevir Holdings Co Cash Flow for Dividends Related Terms
Noevir Holdings Co Cash Flow for Dividends Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's Cash Flow for Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co Cash Flow for Dividends Calculation
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of 円-57 Mil mean?
Noevir Holdings Co (TSE:4928) has a Cash Flow for Dividends of 円-57 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Noevir Holdings Co and its competitors.
Is Noevir Holdings Co's Cash Flow for Dividends too high?
Noevir Holdings Co's current Cash Flow for Dividends is 円-57 Mil. Overall, Noevir Holdings Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's Cash Flow for Dividends compare to PG and CL?
Noevir Holdings Co's Cash Flow for Dividends of 円-57 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Consumer Packaged Goods company?
A good Cash Flow for Dividends depends on the Consumer Packaged Goods industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Noevir Holdings Co and its competitors. Noevir Holdings Co's current Cash Flow for Dividends is 円-57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,265.32, compared to a current price of 円4,585.00 — trading 12.9% below its estimated fair value. The current Cash Flow for Dividends is 円-57 Mil. Noevir Holdings Co's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current Cash Flow for Dividends is 円-57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,585.00 is trading 12.9% below its estimated GF Value™ of 円5,265.32.
GuruFocus considers Noevir Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:4928:
Cash Flow for Dividends: 円-57 Mil
GF Value™: 円5,265.32 vs. price of 円4,585.00 (12.9% below fair value)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
79GF Score
Get the complete analysis for TSE:4928
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
